Providers’ HIV Prevention Discussions with HIV-Seropositive Injection Drug Users
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.
- Bakken, S., Holzemer, W. L., Brown, M., Powell-Cope, G. M., Turner, J. G., and Inouye, J. (2000). Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care and STDs, 14, 189–197. CrossRef
- Centers for Disease Control and Prevention. (2002). HIV/AIDS Surveillance Report, 14.
- Centers for Disease Control and Prevention. (2003). Incorporating HIV prevention into the care of persons living with HIV: Recommendations of the Centers for Disease Control and Prevention, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of America. MMWR Morbidity and Mortality Weekly Reports, 52(RR–12), 1–24.
- Deren, S., Beardsley, M., Coyle, S., and Singer, M. (1998). HIV serostatus and risk behaviors in a multisite sample of drug users. Journal of Psychoactive Drugs, 30, 239–245.
- Derogatis, L. R., and Spencer, P. M. (1982). The Brief Symptom Inventory (BSI): Administration, scoring, and procedural manual. Baltimore: John Wiley.
- Dodge, W. T., BlueSpruce, J., Grothaus, L., Rebolledo, V., McAfee, T. A., and Carey, J. W. (2001). Enhancing primary care HIV prevention: A comprehensive clinical intervention. American Journal of Preventive Medicine, 20, 177–183. CrossRef
- Duffus, W. A., Barragan, M., Metsch, L., Krawczyk, C. S., Loughlin, A. M., and Gardner, L. I. (2003). Effect of physician specialty on counseling practices and medical referral patterns among physicians caring for disadvantaged human immunodeficiency virus–infected populations. Clinical Infectious Diseases, 36, 1577–1584. CrossRef
- Gerbert, B., Brown, B., Volberding, P., Cooke, M., Caspers, N., and Love, C. (1999). Physicians’ transmission prevention assessment and counseling practices with their HIV positive patients. AIDS Education and Prevention, 11, 307–320.
- Gerbert, B., Moe, J. C., Saag, M. S., Benson, C. A., Jacobsen, D. M., and Feraios, A. (2001). Toward a definition of HIV expertise: A survey of experienced HIV physicians. AIDS Patient Care and STDs, 15, 321–330. CrossRef
- Marks, G., Richardson, J. L., Crepaz, N., Stoyanoff, S., Milam, J., and Kempker, C. (2002). Are HIV providers talking with patients about safer sex and disclosure?: A multi–clinic assessment. AIDS, 16, 1953–1957. CrossRef
- Margolis, A. D., Wolitski, R. J., Parsons, J. T., and Gomez, C. A. (2001). Are healthcare providers talking to HIV–seropositive patients about safer sex? AIDS, 15, 2335–2337. CrossRef
- McGowan, J. P., Shah, S. S., Ganea, C. E., Blum, S., Ernst, J. A., and Irwin, N. K. (2004). Risk behavior for transmission of human immunodeficiency virus (HIV) among HIV–seropositive individuals in an urban setting. Clinical Infectious Diseases, 38, 122–127. CrossRef
- Meredith, K. L., Jeffe, D. B., Mundy, L. M., and Fraser, V. J. (2001). Sources influencing patients in their HIV medication decisions. Health Education and Behavior, 28, 40–50.
- Metsch, L. R., McCoy, C. B., Lai, S., and Miles, C. (1998). Continuing risk behaviors among HIV–seropositive chronic drug users in Miami, Florida. AIDS and Behavior, 2, 161–169. CrossRef
- Metsch, L. R., Pereyra, M., del Rio, C., Gardner, L., Duffus, W., and Dickinson, G. (2004). Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities. American Journal of Public Health, 94, 1186–1192. CrossRef
- Morin, S. F., Koester, K. A., Steward, W. T., Maiorana, A., McLaughlin, M., and Myers, J. J. (2004). Missed opportunities: prevention with HIV–infected patients in clinical care settings. Journal of Acquired Immune Deficiency Syndromes, 36, 960–966.
- Purcell, D. W., Metsch, L. R., Latka, M., Santibanez, S., Gomez, C. A., and Eldred, L. (2004). Interventions for seropositive injectors–research and evaluation: An integrated behavioral intervention with HIV–seropositive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes, 37, S110–S118.
- Richardson, J. L., Milam, J., McCutchan, A., Stoyanoff, S., Bolan, R., Weiss, J., Kemper, C., Larsen, R. A., Hollander, H., Weismuller, P., Chou, C., and Marks, G. (2004). Effect of brief safer–sex counseling by medical providers to HIV–1 seropositive patients: a multi–clinic assessment. AIDS, 18, 1179–1186. CrossRef
- Rogers, E. S., Chamberlin, J., Ellison, M. L., and Crean, T. (1997). A consumer–constructed scale to measure empowerment among users of mental health services. Psychiatric Services, 48, 1042–1047.
- Stewart, A. L., and Camberg, C. J. (1992). Physical functioning measures. In: A. L. Stewart, J. E. Ware (Eds.), Measuring functioning and well–being: The medical outcomes study approach (pp. 86–101). Durham: Duke University Press.
- Tun, W., Celentano, D. D., Vlahov, D., and Strathdee, S. A. (2003). Attitudes toward HIV treatments influence unsafe sexual and injection practices among injection drug users. AIDS, 17, 1953–1962. CrossRef
- Weinhardt, L. S., Kelly, J. A., Brondino, M. J., Rotheram–Borus, M. J., Kirshenbaum, S. B., and Chesney, M. A. (2004). HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. Journal of Acquired Immune Deficiency Syndromes, 36, 1057–1066.
- Providers’ HIV Prevention Discussions with HIV-Seropositive Injection Drug Users
AIDS and Behavior
Volume 10, Issue 6 , pp 699-705
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- Human immunodeficiency virus
- Acquired immunodeficiency syndrome
- Substance abuse, intravenous
- Primary health care
- Prevention and control
- Author Affiliations
- 1. Department of Epidemiology and Public Health, Miller School of Medicine, University of Miami, 1801 NW 9th Avenue, Suite 200, Miami, FL, 33136, USA
- 2. National Center for HIV, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
- 3. Department of Medicine, Montefiore Medical Center, Bronx, New York, USA
- 4. Department of Behavior and Health, John Hopkins School of Public Health, Baltimore, MD, USA
- 5. Center for AIDS Prevention Studies, University of California at San Francisco, San Francisco, CA, USA